We expect Vertex Pharmaceuticals Incorporated (VRTX) to surpass expectations when it reports third-quarter 2024 results on Nov. 4, after market close.The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at $2.68 billion, while the same for earnings is pinned at $4.13 per share.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Let's see how things might have shaped up for the quarter to be reported.Factors Shaping VRTX's Upcoming ResultsVertex currently mark ...